FSH, Agonist of FSH receptor, CAS No.rp174040, Agonist of FSH receptor

CAS: rp174040 Cat. No.: rp174040 PubChem CID: 62819
Disponibile su ordine
QUALITÀ & PUREZZA Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools.
★
Dimensione
Germania (EU)
USA*
Prezzo
Qtà
500μg
rp174040-500μg
Su ordinazione · 8–12 settimane
2.082,49€
1mg
rp174040-1mg
Su ordinazione · 8–12 settimane
3.470,87€
Enter a quantity for the sizes you want to add.

Specifiche

Product Name
FSH, Agonist of FSH receptor, CAS No.rp174040
Sinonimi
Urofollitropin | 1-{19-Amino-7-(2-amino-2-oxoethyl)-13-(butan-2-yl)-10-(1-hydroxyethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl}prolylleucylglycinamide | Fertinex; Fertinorm; Metrodin; Orgafol; Urofollitrophin | Follicle-stimulating hormone | 1-[19-amino-7-(2-amino-2-oxoet Mostra altro
Grado
Moligand™
Specifiche e purezza
Moligand™
Tipo di azione
AGONIST
Meccanismo d'azione
Agonist of FSH receptor
CAS
rp174040
Tipo di molecola
Peptidi
Product Line
Prodotti biologici
Stoccaggio e spedizione
Condizioni di conservazione di stoccaggio
Room temperature

Dati avanzati

Obiettivi associati (umani)
FSHR Tclin Follicle-stimulating hormone receptor (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
Certificati (CoA, COO, BSE/TSE e tabella di analisi)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Informazioni genetiche
Alternate NamesUrofollitropin|1-{19-Amino-7-(2-amino-2-oxoethyl)-13-(butan-2-yl)-10-(1-hydroxyethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carbonyl}prolylleucylglycinamide|Fertinex; Fertinorm; Metrodin; Orgafol; Urofollitrophin|Follicle-stimulating hormone|1-[19-amino-7-(2-amino-2-oxoethyl)-13-butan-2-yl-10-(1-hydroxyethyl)-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]-N-[1-[(2-amino-2-oxoethyl)amino]-4-methyl-1-oxopentan-2-yl]pyrrolidine-2-carbox
Reference
  • 1. Kinetics and inhibition of recombinant human cystathionine gamma-lyase. Toward the rational control of transsulfuration., The Journal of biological chemistry, Steegborn, C C and 7 more authors.
  • 2. Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences., Proceedings of the National Academy of Sciences of the United States of America, Strausberg, Robert L RL and 83 more authors.
  • 3. Genomic basis of cystathioninuria (MIM 219500) revealed by multiple mutations in cystathionine gamma-lyase (CTH)., Human genetics, Wang, Jian J and Hegele, Robert A RA.
  • 4. Cloning and nucleotide sequence of human liver cDNA encoding for cystathionine gamma-lyase., Biochemical and biophysical research communications, Lu, Y Y, O'Dowd, B F BF, Orrego, H H and Israel, Y Y.
  • 5. Single nucleotide polymorphism in CTH associated with variation in plasma homocysteine concentration., Clinical genetics, Wang, J J, Huff, A M AM, Spence, J D JD and Hegele, R A RA.
  • 6. Cystathionine gamma-lyase overexpression inhibits cell proliferation via a H2S-dependent modulation of ERK1/2 phosphorylation and p21Cip/WAK-1., The Journal of biological chemistry, Yang, Guangdong G, Cao, Kun K, Wu, Lingyun L and Wang, Rui R.
  • 7. The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)., Genome research, Gerhard, Daniela S DS and 115 more authors.
  • 8. Towards a proteome-scale map of the human protein-protein interaction network., Nature, Rual, Jean-François JF and 37 more authors.
  • 9. The DNA sequence and biological annotation of human chromosome 1., Nature, Gregory, S G SG and 178 more authors.
  • 10. Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer., International journal of cancer, Moore, Lee E LE and 14 more authors. more
Calcolatori di soluzioni
Recensioni

Recensioni dei clienti

Application Protocols

Item-specific tested applications and recommended protocols: Not specified for this item; refer to CoA/Spec Sheet.

General/literature example protocols (for research context only):

  • cAMP accumulation assay (FSHR):
    • Plate FSHR-expressing cells (e.g., HEK293/CHO) 18–24 h prior. Equilibrate in assay buffer (HBSS + 20 mM HEPES + 0.1% BSA) with phosphodiesterase inhibitor (e.g., IBMX) as per platform.
    • Treat with serial dilutions of FSH; incubate 15–30 min at 37 °C.
    • Detect cAMP via HTRF, AlphaScreen, or luciferase reporter. Fit concentration–response to determine EC50 and Emax.
  • Binding displacement assay:
    • Incubate membranes or intact cells expressing FSHR with fixed radiolabeled/fluorescent FSH tracer and increasing concentrations of unlabeled FSH.
    • Equilibrate at 4–25 °C; separate bound/free and quantify. Analyze Ki using Cheng–Prusoff under equilibrium assumptions.
  • ELISA standard curve preparation:
    • Prepare serial dilutions in assay buffer containing 0.1% BSA. Avoid repeated freeze–thaw; use single-use aliquots.

Critical practices:

  • Use low-bind plastics, include carrier protein, and control temperature to maintain activity. Validate that any surfactants or additives do not interfere with detection chemistry.

These are illustrative only; adapt to your platform and consult the CoA for any item-specific instructions.

Biological Roles

General/literature overview of FSH biology (not item-specific, for research context only):

  • Molecular nature: Heterodimeric glycoprotein hormone produced by anterior pituitary gonadotropes. Composed of a common α-subunit and an FSH-specific β-subunit; both are glycosylated.
  • Receptor: Binds the follicle-stimulating hormone receptor (FSHR), a Class A GPCR primarily expressed in ovarian granulosa cells and testicular Sertoli cells; activates Gs–adenylyl cyclase signaling, elevating intracellular cAMP and downstream PKA pathways.
  • Functional roles: Regulates gametogenesis by promoting follicular development and Sertoli cell function; modulates expression of aromatase, inhibin/activin feedback, and other differentiation markers in its target cells.
  • Signaling complexity: Glycoform heterogeneity (sialylation, fucosylation) and subunit-specific sequences can bias receptor signaling, trafficking, and β-arrestin recruitment, leading to context-dependent responses.
  • Systems integration: Operates within the hypothalamic–pituitary–gonadal axis, subject to regulation by GnRH, sex steroids, and inhibins/activins.
  • Experimental usage: In vitro, FSH serves as a defined ligand to probe GPCR pharmacology, receptor desensitization, and to calibrate immunoassays for hormone detection.

Caveats:

  • Biological potencies reported in literature vary with source, isoform composition, and assay platform. For quantitative work, standardize against a reference within your assay.

Note: This information is provided to contextualize research use only. No clinical or therapeutic claims are made or implied.

Buffer Applications

Item-specific buffer recommendations: Not specified for this item; refer to CoA/Spec Sheet.

General/literature guidance for preparing and using protein hormone stocks:

  • Stock preparation: Reconstitute lyophilized protein in sterile, near-neutral buffer (e.g., PBS, HEPES, or culture medium) to a convenient concentration. Include 0.1–1% carrier protein (BSA or HSA) and/or 5–10% glycerol to reduce adsorption and improve freeze–thaw tolerance.
  • Working solutions: Prepare fresh dilutions in assay-compatible buffer or complete media. Avoid repeated pipetting through air to limit foaming and denaturation.
  • pH range: Most assays utilize pH 7.2–7.4; verify compatibility with your cells/biochemical system. Extreme pH may compromise structure.
  • Sterility: For sterile applications, filter through 0.2 µm low-protein-binding filters (PES/PVDF). Do not heat-sterilize.
  • Stability aids: Trace non-ionic surfactant (e.g., 0.01% polysorbate 20) can mitigate interface-induced aggregation; confirm that the surfactant is compatible with the assay.
  • Adsorption control: Use low-bind tubes and tips for sub-µg/mL operations. Pre-block plasticware with buffer + carrier protein when necessary.

Recipes (examples, non-item-specific):

  • PBS, pH 7.4: 10 mM phosphate, 137 mM NaCl, 2.7 mM KCl; optionally 0.1% BSA.
  • HEPES-buffered saline: 20 mM HEPES, 150 mM NaCl, pH 7.4.

Always consult the product CoA for any item-specific formulation, excipients, and reconstitution instructions.

Green Alternatives

Context:

  • As a protein ligand used in biochemical and cell-based assays, FSH does not function as a process solvent or typical reaction reagent; therefore, the conventional concept of “green solvent/reagent substitution” is largely inapplicable.

General sustainability considerations for protein-based reagents (literature-based):

  • Formulation: Prefer aqueous buffers over organic cosolvents; avoid unnecessary use of DMSO or acetonitrile to reduce organic waste and denaturation risk.
  • Concentrate usage: Prepare higher-concentration stock solutions (within stability limits) to minimize packaging and cold-chain burden across multiple experiments.
  • Assay miniaturization: Adopt microplate miniaturization (e.g., 384-/1536-well formats) to reduce reagent consumption and waste.
  • Reusability: Where permissible, pool unused aliquots from the same session under aseptic conditions to minimize discard, recognizing potential activity loss with repeated handling.
  • Cold-chain optimization: Since this item is listed for room-temperature storage, confirm with CoA whether cold-chain shipping is unnecessary; optimizing shipping temperature reduces environmental impact.

Alternatives/adjacent reagents:

  • For FSHR studies where protein hormones are undesirable (stability, variability), consider small-molecule FSHR agonists/antagonists or stabilized peptide mimetics (literature) that may offer improved shelf-life and simplified handling. Tradeoff: May not recapitulate native glycoform-dependent signaling.

Item-specific green attributes or certifications: Not specified for this item; refer to CoA/Spec Sheet.

Pharmaceutical Uses

This product is designated for research use only; it is not intended for diagnostic, clinical, or therapeutic applications.

Research/manufacturing context (general/literature, not item-specific):

  • Reference standard: FSH may be employed as a laboratory reference or system suitability control in analytical methods (e.g., immunoassays) that quantify or detect FSH in research samples.
  • Bioassay calibration: Used to benchmark cell-based potency assays targeting FSHR signaling in discovery settings.
  • Process development tool: In bioprocess R&D, native ligands are sometimes used to challenge receptor-expressing cell banks or to qualify bioassay performance; such use should be qualified with internal standards and traceability.

Regulatory status and pharmacopeia:

  • Any compendial status, GMP grade availability, or therapeutic-use suitability for this specific catalog item is Not specified for this item; refer to CoA/Spec Sheet.

Formulation/excipient role:

  • FSH is not typically used as a pharmaceutical excipient. In research formulations, it can be incorporated into aqueous buffers with stabilizers (e.g., BSA, sugars) to maintain activity during handling, but such practices must be validated in-house.

Important: Do not use this material in humans or animals for therapeutic, diagnostic, or clinical purposes.

Physical Properties

Item-specific properties from Product Data:

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.

Storage and shipping:

  • Storage Conditions: Room temperature (per Product Data).
  • Shipped In: Not specified for this item; refer to CoA/Spec Sheet.

General/literature properties for FSH (protein reference values, not item-specific):

  • Macromolecular nature: Heterodimeric glycoprotein; typical apparent MW ~28–35 kDa by SDS-PAGE depending on glycosylation; monoisotopic mass not defined due to heterogeneous glycans.
  • Isoelectric point (pI): Broadly distributed; more sialylated isoforms are more acidic (pI ~3–5), less sialylated isoforms shift higher (literature, isoform-dependent).
  • Solubility: Readily soluble in aqueous buffers; improved stability with carrier proteins (e.g., 0.1–1% BSA) and isotonic salts; poor solubility in organic solvents (literature).
  • Thermal behavior: Denatures on heating; unfolding typically observed >50–60 °C depending on buffer and excipients (literature DSC/CD data).
  • Aggregation: Propensity increases with agitation, interface exposure, or low ionic strength; mitigated by gentle handling, surfactants (e.g., 0.01% polysorbate 20), and appropriate pH/tonicity (literature guidance).
  • pH stability: Often handled near neutral pH (6.5–7.5); extremes can promote deamidation or aggregation (literature).

Not applicable to proteins:

  • Boiling point, melting point, vapor pressure, logP, refractive index: Not applicable to macromolecular proteins in the conventional sense.
Quality and Grades

Item-specific quality details from Product Data:

  • Grade/Purity: Moligand™

Interpretation and general guidance:

  • Moligand™ designates Aladdin Scientific’s screening-library grade intended for discovery workflows (e.g., binding, receptor activation/inhibition, and phenotypic screens). It emphasizes identity and suitability for research assays rather than pharmacopeial compliance.
  • What Moligand™ typically implies (general, not item-specific):
    • Identity confirmation by orthogonal analytical methods (e.g., LC/MS, peptide mapping) appropriate to the material class.
    • Fit-for-purpose purity for in vitro research; UV background and endotoxin targets may be controlled for biochemical assays, but exact limits are item-specific.
  • Item-specific analytical specifications (e.g., exact purity %, sequence verification, glycoform profile, endotoxin, residual solvents, water content): Not specified for this item; refer to CoA/Spec Sheet.

Lot-to-lot considerations for protein ligands (general):

  • Bioactivity may vary with glycosylation/isoform distribution; benchmarking each lot in a reference cell-based assay (e.g., FSHR cAMP readout) is recommended.
  • Stability can depend on excipients and lyophilization cycle; verify reconstitution and storage recommendations on the CoA.

Suitability:

  • For research use only (per Product Data). Not intended for diagnostic, clinical, or therapeutic use.
Reaction and Applications

Applicability to chemical synthesis:

  • FSH is a macromolecular protein ligand and is not used as a solvent or traditional small-molecule reagent. Consequently, classical organic reaction applications (e.g., Grignard, cross-coupling) are not applicable.

Research applications (general/literature, not item-specific):

  • Receptor pharmacology: FSH is the cognate agonist of the follicle-stimulating hormone receptor (FSHR, a Class A GPCR). It is used to benchmark FSHR signaling in cell-based assays (e.g., cAMP accumulation via Gs, CRE-luciferase reporters, β-arrestin recruitment) and binding assays (radioligand or fluorescent tracer displacement).
  • Systems biology: Serves as a defined input to study gonadotrope signaling networks, receptor desensitization/internalization, and glycoform-dependent signaling bias.
  • Analytical controls: Employed as a positive control for immunoassays detecting FSH or FSHR-related pathway markers.
  • Bioprocess/analytics: Can act as a reference material for method qualification (e.g., ELISA standard curves), provided concentration is traceable; verify with CoA.

Practical tips (general):

  • Activity validation: Calibrate potency in your specific assay format; EC50 often lies in the sub-nanomolar to low-nanomolar range depending on cell line and receptor expression (literature).
  • Handling: Minimize surface adsorption by adding carrier proteins and using low-bind plastics. Avoid vigorous mixing; gently invert or roll.
  • Temperature: Keep on ice during assay setup to limit proteolysis; warm to 37 °C only during incubation steps if required by the protocol.

Item-specific application notes: Not specified for this item; refer to CoA/Spec Sheet.

Reaction Conditions

Classical reaction conditions (solvent, temperature, catalysts, yields) do not apply to FSH, as it is not a chemical reagent for synthesis.

General/literature guidance for bioassay conditions (not item-specific):

  • Cell-based assays: FSHR-expressing cells (e.g., engineered HEK293, CHO, or granulosa-derived lines) are commonly used. Incubations are carried out in serum-free or low-serum media at 37 °C, 5% CO2, with endpoints such as cAMP, CRE-luciferase, or β-arrestin recruitment measured after 10–60 minutes depending on the readout.
  • Binding assays: Equilibrium binding at 4–25 °C in buffered saline with 0.1% BSA to reduce nonspecific adsorption. For competition binding, a fixed tracer concentration with serial dilutions of FSH defines Ki/IC50 under defined receptor densities.
  • Buffer composition: Near-neutral pH (7.2–7.4), isotonic ionic strength (≈150 mM NaCl). Add 0.01% non-ionic surfactant to limit adsorption where compatible.
  • Plate format: 96- to 384-well plates with low-binding surfaces are recommended to enhance reproducibility at low ligand concentrations.
  • Kinetics: Association and dissociation kinetics can be measured with label-free or fluorescent techniques; ensure temperature control and gentle mixing.

Note:

  • Exact concentrations, incubation times, and data analysis parameters should be optimized empirically for each cell line and detection platform. Any item-specific potency or recommended conditions are Not specified for this item; refer to CoA/Spec Sheet.
Safety and Handling

Item-specific hazard data from Product Data:

  • Signal Word: Not specified for this item; refer to SDS.
  • H-Statements: Not specified for this item; refer to SDS.
  • GHS Classification: Not specified for this item; refer to SDS.
  • Pictograms: Not specified for this item; refer to SDS.

General laboratory handling guidance (proteins/biologics; research use only):

  • Use in a certified chemical/biological laboratory with appropriate PPE: lab coat, safety glasses, and disposable nitrile gloves. Avoid inhalation of powders/aerosols and contact with skin/eyes.
  • Engineering controls: Handle powders/lyophilized material in a fume hood or biosafety cabinet to minimize aerosolization. Use low-retention tips and protein-friendly plastics to reduce adsorption.
  • Hygiene: Do not eat, drink, or smoke in work areas. Wash hands thoroughly after handling. Decontaminate benches and equipment after use.
  • Incompatibilities: Avoid strong oxidizers, extreme pH, proteases, and repeated freeze–thaw cycles which may degrade protein integrity.
  • First aid (general): If inhaled, move to fresh air; if on skin, wash with soap and water; if in eyes, rinse cautiously with water for several minutes; if ingested, rinse mouth. Seek medical attention if symptoms persist. Always follow institutional SOPs.
  • Spill/leak: Avoid creating dust; gently cover with damp disposable towels, collect, and dispose per local regulations.
  • Waste: Dispose as laboratory chemical/biological waste per institutional guidelines.

Authoritative information: Always consult the product-specific SDS and CoA for definitive hazard, exposure limits, and emergency measures.

Solvent Selection

Item-specific solvent data: Not specified for this item; refer to CoA/Spec Sheet.

General guidance for FSH (protein ligand) handling:

  • Primary medium: Aqueous buffers (e.g., PBS, HEPES, Tris) at near-neutral pH are typically used. Inclusion of carrier protein (0.1–1% BSA) and/or stabilizers (e.g., 5–10% glycerol, 0.01% polysorbate 20) can reduce adsorption and aggregation in low-µg/mL regimes.
  • Organic solvents: Not recommended. High levels of DMSO, acetonitrile, ethanol can denature proteins. If cosolvent use is unavoidable (e.g., for plate spotting), keep DMSO ≤5% v/v and validate activity (literature practice).
  • Filtration: Use low-protein-binding 0.2 µm filters (PES or PVDF) if sterility is required; avoid excessive pressure/shear.
  • Adsorption minimization: Pre-rinse plastics with buffer containing BSA or use siliconized/low-bind plastics when working at low concentrations.

When to choose which buffer (literature-based, non-item-specific):

  • PBS (pH 7.2–7.4): Routine handling, short-term storage, and cell-based assays.
  • HEPES (pH 7.2–7.6): CO2-independent systems or live-cell imaging where pH stability is needed outside incubators.
  • Tris (pH 7.4–8.0): Biochemical assays; note temperature-dependent pKa.

Comparison notes:

  • For receptor activation assays, isotonic buffers compatible with culture media are preferred; avoid chelators or additives that may affect GPCR signaling. Validate any surfactants for lack of cytotoxicity at the intended use level.
Storage and Reconstitution

Item-specific from Product Data:

  • Storage Conditions: Room temperature.
  • Reconstitution protocol, diluent, stabilizers, aliquoting guidance: Not specified for this item; refer to CoA/Spec Sheet.

General/literature guidance for protein ligands (not item-specific):

  • Upon receipt: Inspect packaging for damage and verify integrity. If lyophilized, allow container to equilibrate to room temperature before opening to avoid condensation.
  • Reconstitution: Use sterile, near-neutral buffer (e.g., PBS or HEPES, pH ~7.2–7.4). Add carrier protein (0.1–1% BSA/HSA) and/or 5–10% glycerol to minimize adsorption and improve stability. Gently swirl—do not vortex.
  • Aliquoting: Prepare single-use aliquots in low-bind tubes to avoid multiple freeze–thaw cycles.
  • Short-term storage: 2–8 °C for hours to days depending on formulation; avoid microbial contamination.
  • Long-term storage: −20 to −80 °C is commonly used for reconstituted proteins with stabilizers; stability is formulation-dependent. Validate retention of activity after storage.
  • Freeze–thaw: Minimize cycles; thaw on ice and mix gently. Consider snap-freezing aliquots in a dry ice/ethanol bath before transferring to long-term storage.
  • Light and agitation: Protect from strong light and mechanical agitation to reduce denaturation.

Authoritative guidance:

  • Follow the product-specific CoA/SDS for definitive storage, reconstitution medium, concentration limits, and shelf-life. Where Product Data specifies room-temperature storage, confirm whether this applies to lyophilized state only.
Structure and Identity

Item-specific identifiers from Product Data:

  • SKU: rp174040
  • Product Name: FSH
  • CAS: rp174040 (internal catalog placeholder)
  • PubChem CID: 62819 (literature mapping to follicle-stimulating hormone)
  • InChIKey: Not specified for this item; refer to CoA/Spec Sheet.
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.

Item-specific composition:

  • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.

General/literature structural description (for FSH, a glycoprotein hormone):

  • FSH is a heterodimeric glycoprotein composed of a common α-subunit (shared with LH, TSH, hCG) and a hormone-specific β-subunit that confers receptor selectivity.
  • Each subunit is rich in cystine-knot motifs stabilized by multiple disulfide bonds; the β-subunit carries determinant loops for receptor recognition.
  • N-linked glycosylation on both subunits (site occupancy and sialylation vary by isoform) strongly influences isoelectric point, circulatory half-life, and receptor signaling bias.
  • As a high-molecular-mass, post-translationally modified protein, FSH does not have a single definitive molecular formula, SMILES, or InChIKey in the conventional small-molecule sense.
  • 2D schematic: Two non-covalently associated polypeptide chains (α and β), each folded with disulfide-stabilized loops; carbohydrate chains protrude from defined Asn residues; the assembled heterodimer presents a concave receptor-binding surface.

Notes:

  • Any exact sequence, glycoform distribution, and isoform information for this catalog item is Not specified for this item; refer to CoA/Spec Sheet.
Synthetic Utility

Not typically applicable.

Rationale:

  • FSH is a large glycoprotein ligand and does not function as a building block, catalyst, or reagent in conventional chemical synthesis. It lacks the volatility, solubility, and functional group accessibility relevant to standard synthetic methodologies.

Adjacent research utilities (general, not item-specific):

  • Ligand–receptor studies: As an agonist for FSHR, it serves in structure–activity relationship benchmarking of small-molecule or peptide mimetics developed as chemical probes.
  • Affinity tools: Immobilized hormone (via gentle bioconjugation to solid supports) may be used to enrich or profile receptor ectodomain constructs in biochemical pull-down assays; such applications require careful preservation of conformation and activity.

If your objective is chemical synthesis:

  • Consider using small-molecule surrogates or peptide fragments that mimic FSH activity when a chemically tractable probe is needed. These alternatives are better suited to synthesis, derivatization, and SAR workflows.

Item-specific synthetic or derivatization notes: Not specified for this item; refer to CoA/Spec Sheet.

Target Specificity

Item-specific target/antigen data (clone, epitope, species reactivity, isotype) are not applicable, as this product is not an antibody.

From general literature (not item-specific):

  • Endogenous target: Follicle-stimulating hormone receptor (FSHR), a Class A GPCR predominantly expressed in ovarian granulosa and testicular Sertoli cells.

For this catalog item:

  • No validated target-specific testing data, receptor binding constants, or bioactivity specifications are provided. Not specified for this item; refer to CoA/Spec Sheet.

Domande frequenti

How should this product be stored?
Store at room temperature.
What is Moligand??
Moligand? is one of Aladdin Scientific's premium product lines, formulated for high-purity applications across multiple workflows. Compared to standard grades in the same workflow, Moligand? products typically offer tighter specifications, more rigorous QC, and stronger lot-to-lot consistency.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is rp174040.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Hai bisogno di aiuto per scegliere la qualità?

La nostra guida alla selezione delle qualità copre purezza, stato dello stabilizzatore e idoneità all'applicazione per tutte le varianti del nostro catalogo.

Visualizza la guida alle qualità Moligand™ →

Desidera che le inviamo un messaggio quando avremo sconti disponibili?

Ricordamelo più tardi

Grazie! Controlli la sua casella di posta per confermare.

Ops! Le notifiche sono disabilitate.